A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer

NCT01383707 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: 5-Fluorouracil (5-FU)
DRUG: Bevacizumab
DRUG: Levofolinic acid
DRUG: Oxaliplatin

Sponsor

Hoffmann-La Roche